Direct Effects of Phosphate on Vascular Cell Function

Edmonds, 1982, Medial arterial calcification and diabetic neuropathy, Br Med J (Clin Res Ed), 284, 928, 10.1136/bmj.284.6320.928 Giachelli, 2009, The emerging role of phosphate in vascular calcification, Kidney Int, 75, 890, 10.1038/ki.2008.644 Goodman, 2004, Vascular calcification in chronic kidney disease, Am J Kidney Dis, 43, 572, 10.1053/j.ajkd.2003.12.005 London, 2003, Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality, Nephrol Dial Transplant, 18, 1731, 10.1093/ndt/gfg414 Guerin, 2001, Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure, Circulation, 103, 987, 10.1161/01.CIR.103.7.987 Vanholder, 2005, Chronic kidney disease as cause of cardiovascular morbidity and mortality, Nephrol Dial Transplant, 20, 1048, 10.1093/ndt/gfh813 Ahmed, 2001, Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells, Am J Kidney Dis, 37, 1267, 10.1053/ajkd.2001.24533 Shao, 2006, Molecular mechanisms of vascular calcification: lessons learned from the aorta, Arterioscler Thromb Vasc Biol, 26, 1423, 10.1161/01.ATV.0000220441.42041.20 Otto, 1999, Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly, N Engl J Med, 341, 142, 10.1056/NEJM199907153410302 Umana, 2003, Valvular and perivalvular abnormalities in end-stage renal disease, Am J Med Sci, 325, 237, 10.1097/00000441-200304000-00010 Block, 1998, Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: a national study, Am J Kidney Dis, 31, 607, 10.1053/ajkd.1998.v31.pm9531176 Young, 2005, Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study, Kidney Int, 67, 1179, 10.1111/j.1523-1755.2005.00185.x Dhingra, 2007, Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community, Arch Intern Med, 167, 879, 10.1001/archinte.167.9.879 Noordzij, 2006, Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients, Nephrol Dial Transplant, 21, 2513, 10.1093/ndt/gfl257 Tentori, 2008, Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS), Am J Kidney Dis, 52, 519, 10.1053/j.ajkd.2008.03.020 Block, 2004, Mineral metabolism, mortality, and morbidity in maintenance hemodialysis, J Am Soc Nephrol, 15, 2208, 10.1097/01.ASN.0000133041.27682.A2 Chertow, 2002, Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients, Kidney Int, 62, 245, 10.1046/j.1523-1755.2002.00434.x Block, 2007, Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients, Kidney Int, 71, 438, 10.1038/sj.ki.5002059 Russo, 2007, The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer, Kidney Int, 72, 1255, 10.1038/sj.ki.5002518 Qunibi, 2008, A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study, Am J Kidney Dis, 51, 952, 10.1053/j.ajkd.2008.02.298 Kestenbaum, 2005, Serum phosphate levels and mortality risk among people with chronic kidney disease, J Am Soc Nephrol, 16, 520, 10.1681/ASN.2004070602 Tonelli, 2005, Relation between serum phosphate level and cardiovascular event rate in people with coronary disease, Circulation, 112, 2627, 10.1161/CIRCULATIONAHA.105.553198 Hruska, 2008, Hyperphosphatemia of chronic kidney disease, Kidney Int, 74, 148, 10.1038/ki.2008.130 Levin, 2007, Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease, Kidney Int, 71, 31, 10.1038/sj.ki.5002009 Farzaneh-Far, 2005, Biology of vascular calcification in renal disease, Nephron Exp Nephrol, 101, e134, 10.1159/000087578 O’Neill, 2007, The fallacy of the calcium-phosphorus product, Kidney Int, 72, 792, 10.1038/sj.ki.5002412 Shanahan, 1993, Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells, Circ Res, 73, 193, 10.1161/01.RES.73.1.193 Jono, 2000, Phosphate regulation of vascular smooth muscle cell calcification, Circ Res, 87, E10, 10.1161/01.RES.87.7.e10 Block, 2000, Prevalence and clinical consequences of elevated Ca × P product in hemodialysis patients, Clin Nephrol, 54, 318 Steitz, 2001, Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers, Circ Res, 89, 1147, 10.1161/hh2401.101070 Lomashvili, 2006, Chemical and hormonal determinants of vascular calcification in vitro, Kidney Int, 69, 1464, 10.1038/sj.ki.5000297 Lomashvili, 2004, Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin, J Am Soc Nephrol, 15, 1392, 10.1097/01.ASN.0000128955.83129.9C Wada, 1999, Calcification of vascular smooth muscle cell cultures: inhibition by osteopontin, Circ Res, 84, 166, 10.1161/01.RES.84.2.166 El-Abbadi, 2009, Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin, Kidney Int, 75, 1297, 10.1038/ki.2009.83 Graciolli, 2009, Phosphorus overload and PTH induce aortic expression of Runx2 in experimental uraemia, Nephrol Dial Transplant, 24, 1416, 10.1093/ndt/gfn686 Speer, 2009, Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries, Circ Res, 104, 733, 10.1161/CIRCRESAHA.108.183053 Shroff, 2008, Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis, Circulation, 118, 1748, 10.1161/CIRCULATIONAHA.108.783738 Kaden, 2004, Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis, J Heart Valve Dis, 13, 560 Tyson, 2003, Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification, Arterioscler Thromb Vasc Biol, 23, 489, 10.1161/01.ATV.0000059406.92165.31 Moe, 2003, Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels, Kidney Int, 63, 1003, 10.1046/j.1523-1755.2003.00820.x Schlieper, 2010, Ultrastructural analysis of vascular calcifications in uremia, J Am Soc Nephrol, 21, 689, 10.1681/ASN.2009080829 Román-García, 2010, High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression, Bone, 46, 121, 10.1016/j.bone.2009.09.006 Takeda, 1999, Sodium-dependent phosphate co-transporters, Int J Biochem Cell Biol, 31, 377, 10.1016/S1357-2725(98)00124-1 Werner, 1998, Na+-dependent phosphate cotransporters: the NaPi protein families, J Exp Biol, 201, 3135, 10.1242/jeb.201.23.3135 Boyer, 1998, Immunodetection of a type III sodium-dependent phosphate cotransporter in tissues and OK cells, Biochim Biophys Acta, 1368, 73, 10.1016/S0005-2736(97)00159-4 Kavanaugh, 1994, Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters, Proc Natl Acad Sci U S A, 91, 7071, 10.1073/pnas.91.15.7071 Sugitani, 2003, Characterization of an in vitro model of calcification in retinal pigmented epithelial cells, J Atheroscler Thromb, 10, 48, 10.5551/jat.10.48 Chen, 2002, Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells, Kidney Int, 62, 1724, 10.1046/j.1523-1755.2002.00625.x Li, 2006, Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification, Circ Res, 98, 905, 10.1161/01.RES.0000216409.20863.e7 Villa-Bellosta, 2007, Characterization of phosphate transport in rat vascular smooth muscle cells: implications for vascular calcification, Arterioscler Thromb Vasc Biol, 27, 1030, 10.1161/ATVBAHA.106.132266 Williams, 1979, Structure–activity relationship of inhibitors of hydroxyapatite formation, Biochem J, 184, 181, 10.1042/bj1840181 Fleisch, 1970, The inhibitory effect of phosphonates on the formation of calcium phosphate crystals in vitro and on aortic and kidney calcification in vivo, Eur J Clin Invest, 1, 12, 10.1111/j.1365-2362.1970.tb00591.x Villa-Bellosta, 2009, Phosphonoformic acid prevents vascular smooth muscle cell calcification by inhibiting calcium-phosphate deposition, Arterioscler Thromb Vasc Biol, 29, 761, 10.1161/ATVBAHA.108.183384 Villa-Bellosta, 2009, Vascular smooth muscle cell calcification and SLC20 inorganic phosphate transporters: effects of PDGF, TNF-alpha, and Pi, Pflugers Arch, 458, 1151, 10.1007/s00424-009-0688-5 Festing, 2009, Generation of mouse conditional and null alleles of the type III sodium-dependent phosphate cotransporter PiT-1, Genesis, 47, 858 Li, 2008, BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells, Atherosclerosis, 199, 271, 10.1016/j.atherosclerosis.2007.11.031 Chen, 2006, The mechanisms of uremic serum-induced expression of bone matrix proteins in bovine vascular smooth muscle cells, Kidney Int, 70, 1046, 10.1038/sj.ki.5001663 Mathew, 2008, The mechanism of phosphorus as a cardiovascular risk factor in CKD, J Am Soc Nephrol, 19, 1092, 10.1681/ASN.2007070760 Johnson, 2008, Transglutaminase 2 is central to induction of the arterial calcification program by smooth muscle cells, Circ Res, 102, 529, 10.1161/CIRCRESAHA.107.154260 Lorand, 2003, Transglutaminases: crosslinking enzymes with pleiotropic functions, Nat Rev Mol Cell Biol, 4, 140, 10.1038/nrm1014 Prosdocimo, 2010, Regulation of vascular smooth muscle cell calcification by extracellular pyrophosphate homeostasis: synergistic modulation by cyclic AMP and hyperphosphatemia, Am J Physiol Cell Physiol, 298, C702, 10.1152/ajpcell.00419.2009 Huang, 2008, Phosphate and pyrophosphate mediate PKA-induced vascular cell calcification, Biochem Biophys Res Commun, 374, 553, 10.1016/j.bbrc.2008.07.062 Moe, 2008, Mechanisms of vascular calcification in chronic kidney disease, J Am Soc Nephrol, 19, 213, 10.1681/ASN.2007080854 Ketteler, 2005, Fetuin-A and extraosseous calcification in uremia, Curr Opin Nephrol Hypertens, 14, 337, 10.1097/01.mnh.0000172719.26606.6f Silverstein, 2009, Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease, Pediatr Nephrol, 24, 1445, 10.1007/s00467-008-1046-0 Tanikawa, 2009, Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK, J Vasc Res, 46, 572, 10.1159/000226225 Reynolds, 2004, Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD, J Am Soc Nephrol, 15, 2857, 10.1097/01.ASN.0000141960.01035.28 Shroff, 2010, Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification, J Am Soc Nephrol, 21, 103, 10.1681/ASN.2009060640 Son, 2006, Statins protect human aortic smooth muscle cells from inorganic phosphate-induced calcification by restoring Gas6-Axl survival pathway, Circ Res, 98, 1024, 10.1161/01.RES.0000218859.90970.8d Collett, 2003, Receptor tyrosine kinase Axl modulates the osteogenic differentiation of pericytes, Circ Res, 92, 1123, 10.1161/01.RES.0000074881.56564.46 Son, 2007, Gas6/Axl-PI3K/Akt pathway plays a central role in the effect of statins on inorganic phosphate-induced calcification of vascular smooth muscle cells, Eur J Pharmacol, 556, 1, 10.1016/j.ejphar.2006.09.070 Ewence, 2008, Calcium phosphate crystals induce cell death in human vascular smooth muscle cells: a potential mechanism in atherosclerotic plaque destabilization, Circ Res, 103, e28, 10.1161/CIRCRESAHA.108.181305 Sage A, Lu J, Tintut Y, Demer L. Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. Kidney Int. In press. Bertipaglia, 2003, Cell characterization of porcine aortic valve and decellularized leaflets repopulated with aortic valve interstitial cells: the VESALIO Project (Vitalitate Exornatum Succedaneum Aorticum Labore Ingenioso Obtenibitur), Ann Thorac Surg, 75, 1274, 10.1016/S0003-4975(02)04706-9 Mathieu, 2005, Calcification of human valve interstitial cells is dependent on alkaline phosphatase activity, J Heart Valve Dis, 14, 353 Rattazzi, 2008, Clones of interstitial cells from bovine aortic valve exhibit different calcifying potential when exposed to endotoxin and phosphate, Arterioscler Thromb Vasc Biol, 28, 2165, 10.1161/ATVBAHA.108.174342 Mohler, 1999, Identification and characterization of calcifying valve cells from human and canine aortic valves, J Heart Valve Dis, 8, 254 Niederhoffer, 1997, Calcification of medial elastic fibers and aortic elasticity, Hypertension, 29, 999, 10.1161/01.HYP.29.4.999 Bobryshev, 1995, Calcified deposit formation in intimal thickenings of the human aorta, Atherosclerosis, 118, 9, 10.1016/0021-9150(95)05588-N Hosaka, 2009, Elastin degradation accelerates phosphate-induced mineralization of vascular smooth muscle cells, Calcif Tissue Int, 85, 523, 10.1007/s00223-009-9297-8 Bouvet, 2008, Sequential activation of matrix metalloproteinase 9 and transforming growth factor beta in arterial elastocalcinosis, Arterioscler Thromb Vasc Biol, 28, 856, 10.1161/ATVBAHA.107.153056 Rucker, 1974, Calcium binding to elastin, Adv Exp Med Biol, 48, 185, 10.1007/978-1-4684-0943-7_10 Simionescu, 2005, Elastin-derived peptides and TGF-beta1 induce osteogenic responses in smooth muscle cells, Biochem Biophys Res Commun, 334, 524, 10.1016/j.bbrc.2005.06.119 Heldin, 1997, TGF-beta signalling from cell membrane to nucleus through SMAD proteins, Nature, 390, 465, 10.1038/37284 Lee, 2000, Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12, Mol Cell Biol, 20, 8783, 10.1128/MCB.20.23.8783-8792.2000 Navaneethan, 2009, Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials, Am J Kidney Dis, 54, 619, 10.1053/j.ajkd.2009.06.004 Tonelli, 2010, Oral phosphate binders in patients with kidney failure, N Engl J Med, 362, 1312, 10.1056/NEJMra0912522 Kapustin, 2009, Targeting vascular calcification: softening-up a hard target, Curr Opin Pharmacol, 9, 84, 10.1016/j.coph.2008.12.004